|
Targeted activation of autoimmune checkpoints in B cell malignancies
|
5R01CA157644-09
|
$410,875
|
$410,875
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$50,864
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$17,300
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$875
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving Diagnosis and Management of Cancer Immunotherapy-Induced Hypophysitis
|
5R01CA194042-03
|
$370,575
|
$370,575
|
CATUREGLI, PATRIZIO
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S1
|
$59,984
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S2
|
$199,060
|
$1,991
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$70,690
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$10,106
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Immunophenotyping by CyTOF and machine learning
|
ZIA BC 011807
|
$198,401
|
$39,680
|
Altan-Bonnet, Gregoire
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$298,466
|
$298,465
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$298,466
|
$298,465
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
T cell receptor proximal signaling
|
ZIA BC 011715
|
$596,931
|
$298,465
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$61,517
|
Barr, Frederic
|
CCR (NCI)
|
|
Permethrin exposure in NHANES
|
ZIA CP010125 10695
|
$75,640
|
$7,564
|
Berndt, Sonja
|
DCEG (NCI)
|
|
PLCO - Lymphoma
|
ZIA CP010152 10709
|
$72,766
|
$18,191
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Serum Markers of Immunity & Risk of Brain tumors
|
ZIA CP010219 10408
|
$25,970
|
$3,895
|
Berrington, Amy
|
DCEG (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$433,273
|
$64,991
|
Blumberg, Peter
|
CCR (NCI)
|
|
Cancer risk among Japanese A-bomb survivors
|
ZIA CP010132 04016
|
$20,811
|
$4,162
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$820,830
|
$82,083
|
Carrington, Mary
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,365,668
|
$109,253
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Chronic graft-versus-host disease
|
ZIA BC 011549
|
$888,058
|
$1,175,337
|
Cowen, Edward
|
CCR (NCI)
|
|
Anakinra for neutrophilic pustular skin disease
|
ZIA BC 011550
|
$99,782
|
$89,804
|
Cowen, Edward
|
CCR (NCI)
|
|
Cytokines and T Cell Development
|
ZIA BC 009287
|
$483,417
|
$96,683
|
Durum, Scott
|
CCR (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150 10359
|
$120,247
|
$12,025
|
Engels, Eric
|
DCEG (NCI)
|
|
Diet and obesity related exposures in SEER-Medicare
|
ZIA CP010127 10573
|
$49,993
|
$2,500
|
Freedman, Neal
|
DCEG (NCI)
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 10722
|
$362,499
|
$362,499
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803 00355
|
$13,239
|
$13,239
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
$159,441
|
Gonzalez, Frank
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$395,788
|
Gress, Ronald
|
CCR (NCI)
|
|
Multiple Myeloma - Yale case-control
|
ZIA CP010123 02380
|
$27,424
|
$1,371
|
Hofmann, Jonathan
|
DCEG (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$641,445
|
$128,289
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Case referent study of brain tumors in adults
|
ZIA CP010135 04030
|
$207,290
|
$10,364
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
|
ZIA BC 010853
|
$198,095
|
$19,809
|
Klinman, Dennis
|
CCR (NCI)
|
|
Registry studies of biliary tract cancer
|
ZIA CP010218 10827
|
$9,817
|
$982
|
Koshiol, Jill
|
DCEG (NCI)
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$435,190
|
$130,557
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Transcriptional regulation of inflammatory and autoimmune responses
|
ZIA BC 011765
|
$435,190
|
$435,190
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
$59,339
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
TNF Signaling, Cell Death and Cancer
|
ZIA SC 010376
|
$835,691
|
$83,569
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Nitroxides as Protectors Against Oxidative Stress
|
ZIA SC 006387
|
$159,046
|
$79,523
|
Mitchell, James
|
CCR (NCI)
|
|
Cell-free assay technologies for the identification of active compounds
|
ZIA BC 011471
|
$626,698
|
$143,560
|
O'Keefe, Barry
|
CCR (NCI)
|
|
Studies of Receptor Interactions and Effects of Alarmins
|
ZIA BC 009369
|
$905,756
|
$90,576
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Role of T Regulatory Cell Suppression in Autoimmunity and Cancer
|
ZIA BC 010707
|
$100,640
|
$20,128
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$613,782
|
$214,824
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$263,049
|
$131,525
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
NIH Chronic GVHD Study Group
|
ZIA BC 011743
|
$341,645
|
$341,645
|
Pavletic, Steven
|
CCR (NCI)
|
|
Immune-related conditions and risk of gastric cancer in elderly U.S. population
|
ZIA CP010212 10835
|
$10,853
|
$10,853
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Associations of Anti-Parietal Cell and Anti-Intrinsic Factor Antibodies with G
|
ZIA CP010212 10836
|
$21,706
|
$21,706
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$349,312
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
|
ZIA SC 009174
|
$111,468
|
$11,147
|
Roberts, David
|
CCR (NCI)
|
Total relevant funding to Autoimmune Diseases for this search: $11,075,220
|